Similar Search Results

Optimal patent policy for pharmaceutical industry

Izhak, Olena; Saxell, Tanja; Takalo, Tuomas - 2020

Persistent link: https://www.econbiz.de/10012439514

Evaluating the US pharmaceutical patent policy

Izhak, Olena; Saxell, Tanja; Takalo, Tuomas - 2021

The debate on whether COVID-19 vaccine patents are slowing down the pace of vaccination and the recovery from the crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in the US pharmaceutical industry. We estimate the effect...

Persistent link: https://www.econbiz.de/10012802183

Branded response to generic entry : detailing beyond the patent cliff

Hariharan, Vijay Ganesh; Landsman, Vardit; Stremersch, … - In: International journal of research in marketing : IJRM ; … 41 (2024) 3, pp. 567-588

Persistent link: https://www.econbiz.de/10015057567

Patent Protection, Creative Destruction, and Generic Entry in Pharmaceuticals : Evidence from Patent and Pricing Data

Marco, Alan C. - 2006

This paper merges patent citation data with data on pharmaceutical patent expirations, generic entry, and pricing to explore the effects of observable patent characteristics on off-patent and on-patent pharmaceutical pricing. Using a sample of drug patents facing generic entry in the 1990s, I...

Persistent link: https://www.econbiz.de/10012732596

Patent Expiry and Pharmaceutical Market Opportunities at the Nexus of Pricing and Innovation Policy

Jain, Dipak C. - 2012

This paper explores the academic literature and empirical evidence associated with the strategic and tactical opportunities available to pharmaceutical firms confronted with the loss of patent protection on their branded drug. The marketing dimensions of product innovation, pricing and brand...

Persistent link: https://www.econbiz.de/10013099957

The same old medicine but cheaper : the impact of patent expiry on physicians' prescribing behaviour

Fiorentini, Gianluca; Lippi Bruni, Matteo; Mammi, Irene - In: Journal of economic behavior & organization : JEBO 204 (2022), pp. 37-68

Persistent link: https://www.econbiz.de/10014228479

The diffusion of generics after patent expiry in Germany

Blankart, Katharina; Stargardt, Tom - In: The European journal of health economics : HEPAC ; … 17 (2016) 8, pp. 1027-1040

Persistent link: https://www.econbiz.de/10011660160

Product patents and access to innovative medicines in a post-trips-era

Watal, Jayashree; Dai, Rong - 2019 - Manuscript date: 28 March 2019

This WTO working paper studies availability and affordability of new and innovative pharmaceuticals in a post-TRIPS era … the introduction of product patents in pharmaceuticals affect the likelihood of pharmaceutical firms to launch new and … finds that introduction of product patent for pharmaceuticals in the patent law has a positive effect on launch likelihood …

Persistent link: https://www.econbiz.de/10011992779

Optimal incentives for patent challenges in the pharmaceutical industry

Böhme, Enrico; Frank, Jonas Severin; Kerber, Wolfgang - In: Review of industrial organization 59 (2021) 3, pp. 503-528

Persistent link: https://www.econbiz.de/10012659758

Optimal incentives for patent challenges in the pharmaceutical industry

Böhme, Enrico; Frank, Jonas Severin; Kerber, Wolfgang - 2017

Since the patent system relies on private litigation for challenging weak patents, and patent settlements might influence the incentives for challenging patents, the question arises whether the antitrust assessment of patent settlements should also consider their impact on the incentives to...

Persistent link: https://www.econbiz.de/10011579217

1
2
3
4
5
6
7
8
9
10
Next
Last